On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...